Nucleotide Metabolism Flashcards

1
Q

Purines and Pyrimidines:

A

Hypoxanthine is precursor to Adenine

Xanthine is precursor to Guanine

Uracil is aminated to form Cytosine and methylated to form Thymine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Nucleoside and Nucleotide

A

A nucleoside is a pentose sugar that is attached in a N-glycosidic linkage to the purine or pyrimidine base

In a nucleotide a phosphate is esterified to one of the OH groupss, typically attached to the C-5’ of the nucleoside pentose.

Tide = phosphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Synthesis of purine nucleotides via the de nova pathway

A

Linear synthesis pathway:

  1. PRPP –>* phsophoribosylamine —-> IMP#

* = first committed step in de nova synthesis

= first compound with completed purine ring

Branch point pathways:

IMP -> S-AMP -> AMP

IMP -> XMP -> GMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Linear Synthesis

(PRPP –> IMP)

A
  1. Base is built on ribose
  2. 10 step energy costly process (5 ATP)
  3. Gutamine, glycine, aspartate provide nitrogens
  4. Formate and CO2 provide carbons - note that glycine also provides 2 carbons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Branch Point Synthesis

(IMP-> AMP or IMP-> GMP)

A

GTP provides free energy for reaction producing AMP

ATP provides free energy for reaciton producing GMP

ATP And GTP are both regulators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PRPP Synthetase

A
  1. PRPP synthetase provides substrate (PRPP) for purine de novo synthesis
    * D-ribose-5-phosphate gets pyrophase (2 PO4-)
  2. PRPP is also used elsewhere in nucleotide metabolism and in amino acid biosynthesis and so this reaction is not comitted to de novo purine synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Amidophosphoribosyltransferase (ATase)

A
  1. ATase catalyzes the displacement of pyrophosphate by the amino group of glutamine.
    * This reaction is the first comited (and also rate-limiting) step in the de novo synth.
  2. ATase is subject to allosteric control by PRPP and end products of teh pathway (IMP,AMP, and GMP)
    * When PRPP is high, it activates enzyme by monomerization
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Synthesis and interconversion of NDPs and NTPs

A

NMP to NDP done by Adenylate kinase and Guanylate kinase

  • AMP + ATP –> 2ADP
  • GMP + ATP –> GDP + ADP
  • base-specific monophosphate kinases

NDP to NTP done by nucleoside diphosphate kinase

  • GDP + ATP -> GTP + ADP
  • broad specificity

steady state conditions of adenylate kinase:

100X ATP: 10X ADP: 1X AMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Purine Nucleotide Metabolism - Regulation

A

Controlled by relative levels of end products

  1. End products can regulate PRPP synthetase, ATase, and both branch point pathways (feedback regulation)
  2. Branch point synthesis can be stimulated by the end product of the opposite branch (cross-regulation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Degradation and excretion of purine nucleotides

A

No specific order:

  • Dephosphorylation removes phosphate from the pentose sugar
  • Deamination removes the amino group from adenine (C-6) and guanine (C-2)
  • Phosphoroylsis removes the pentose sugar

AMP -> Inosine -> Hypoxathine -> xanthine -> Uric Acid

GMP -> Guanosine -> Guanine -> xanthine -> Uric Acid

*Adenosine is potent coronary vasodilators (treat heart attack)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Xanthine dehydrogenase/oxidase (XDH/XO)

A
  • XDH and XO convert hypoxanthine and xanthine into uric acid
  • encoded by same mRNA
  • XDH can be converted to XO under low O2 conditions
  • By product of XO is H2O2, so not desirable
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Gout - hyperuricemia

A

Uric acid overproduction or underexcretion

Primary gout (inherited metabolic abnormalities)

  1. Overexpression of PRPP synthetase
  2. Deficiency of hypoxanthine guanine phosphoribosyltransferase (HPRT/HGPRT)
    1. inhibits salvage pathway to turn Guanine -> GMP or Hypoxanthine -> AMP
  3. Defects in a family of renal urate transport porteins (80% of cases)

Secondary gout (acquired condition)

  1. Drug intake or unusual dietary habits
    1. meats contain a lot of nucleotides
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment of Gout

A

Use of Allopurinol that is a competitive inhibitior:

  • XDH converts Allopurinol to Alloxanthine (not Xanthine)
  • With less XDH available, less xanthine -> Urate production
  • Can also get into salvage pathway and turn into AMP/GMP and inhibit ATase by feedback mechanism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Xanthinuria

A

Deficiency of Xanthine Dehydrogenase (XDH)

  • reverse disorder as Gout
  • You see increased levels of Guanine, Hypoxanthine and Xanthine
  • No treatments - just limiting nucleotide ingestion to reduce levels
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Immunodeficiency diseases

A
  1. A deficiency of adenosine deaminase (ADA) (removes amino group) –> T-cell and B-cell dysfunction (bubble boy)
  2. A deficiency of purine nucleoside phosphorylase (PNP) (removes pentose sugar) –> impairmen of T-cell function

Both of these diseases lead to 50-100 fold increased dATP or GTP levels in lymphocytes leading to inhibition of Ribonucleotide reductase (DNA synthesis, cell division)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Purine recycling (HPRT)

A

Hypoxanthine-guanine phosphoribosyltransferase (HPRT) can initiate Guanine and Hypoxanthine into the salvage pathway

10% of catabolized purine nucleotides are excreted as uric acid, 90% are salvaged.

The de nova pathway of purine nucleotide synthesis functions to maintain total purines by replacing that which is lost through the exrcretion of uric acid

The salvage pathway, therefore, is normally the major pathway of purine nucleotide synthesis

17
Q

Deficiency of HPRT

A

Can lead to Lesch-Nyhan Syndrome

  • HPRT is lacking or present at low levels (<1% of normal) in affected individuals
  • X chromoome linked (affects males)
  • High levels of uric acid produced -> gout
  • Inadequate feedback inhibition of PRPP synthase and ATase leads to increased rates or PRPP synthesis and de nova purine synthesis
    • GMP and AMP are not being salvaged thus are not inhibiting action of PRPP synthetase and ATase
18
Q

Treatment of Lesch-Nyhan Syndrome

A
  • Deficiency of HPRT activity is correlated with the degree of neurological complications
  • Allupurinol relieves complication of gout, no know treatment for neuro problems
    • Allupurinol binds XDH to decreased Xanthine production
  • Brain has 10-20 times higher HPRT activity than other tissues - lack may lead to an imbalance in purine nucleotides at critical times during development
19
Q

Pyrimidine Nucleotide Metabolism - de novo synthesis

A

Key difference is no PRPP and uses glutamine and bicarbonate as initial substrates

A large trifunctional protein, CAD (steps 1-3), Dihydro-orotate dehydrogenase (DHODH step 4), and UMP synthase (steps 5-6)

End product being UMP which will then branch into C and T

20
Q

Caramoyl Phosphate Synthetase activity of CAD

A
  • CPS II is cytosolic and uses glutamine as the source of the amino group
  • This is the rate limiting step
21
Q

Conversion of UMP to UDP and UTP

A
  • UMP is an intermediate in the synthesis of the other pyrimidine nucleotides (C and T)
  • UMP + ATP –> UDP + ADP by pryimidine monophosphate kinda (specific)
  • UDP + ATP –> UTP + ADP by nucleoside diphosphate kinase (broad specificity)
22
Q

Synthesis of CTP

A

CTP synthetase converts UTP to CTP by addition of a NH2 group from Glutamine

23
Q

Degradation and excretion

A
  • Dephosphorylation removes phosphates
  • Deamination removes base
  • Phosphorolysis removes ribose sugar
  • End products are amino acids that can be fruther metabolized
24
Q

The salvage pathway

A

Uridine is the major recylcing molecule

  • PRPP can provide ribose
25
Q

Inherited Disorders

A
  1. Orotic Aciduria (UMP synthase defiecency)
  • excessive orotic acid in urine and anemia
  • UMP is steps 5 and 6 in de novo pathway
     2. Dihydropyrimidine dehydrogenase defiency 
  • associated with elevated levels of uracil and thymine in body fluids and convulsive disorder
26
Q

Reduction of Ribonucleotides

A

Occurs by Ribonucleotide Reductase (RR) at the level of diphosphates

NDP –> NTP

  • An electron transfer pathway that uses NADPH to provide reducing equivalents

RR activtiy:

  • allosterically regulated by dNTP.
  • dATP accumulates in individuals with adenosine deaminase (ADA) deficiency
    • shuts off RR for other nucleotides
27
Q

Synthesis of Thymidine Nucleotides

A

TMP is synthesized by thymidylate synthase using dUMP as the substrate

  • UDP -> dUDP -> dUMP -> dTMP -> Thymidine
  • requires tetrahydrofolate as methyl transferase - controls rate of nucleotide synthesis
28
Q
A